Clinical trials

Only want trials near your city that fit you? Get alerts

Disease

Country

Status

Phase

Reset

416 trials

NCT06940518
Recruiting
Phase II Trial of Ivonescimab in Previously Treated Patients With Advanced Clear Cell Renal Cell Carcinoma
Phase 2 · United States · 1 site
Registry update: 20 Aug 2026
NCT07067905
Recruiting
Clinical Evaluation of [68Ga]Ga-XT771 PET for Diagnosis in Patients With Glioblastoma and Clear Cell Renal Cell Carcinoma
Early phase 1 · China · 1 site
Registry update: 16 Jul 2025
NCT06903312
Recruiting
Primary Tumor Ablation and Outcome in Metastatic Renal Cell Carcinoma Treated With Immunotherapy Combinations.
Phase 4 · Italy · 1 site
Registry update: 3 Jul 2025
NCT06198296
Recruiting
Immunotherapy For Adults With GPC3-Positive Solid Tumors Using IL-15 and IL-21 Armored GPC3-CAR T Cells
Phase 1 · United States · 1 site
Registry update: 3 Nov 2025
NCT07053462
Recruiting
CRISPR-Edited HLA Donor Kidney Transplant to Reduce Rejection Risk
Phase 1/2 · China · 1 site
Registry update: 8 Jul 2025
NCT07301827
Recruiting
Study on the Diagnostic Value of Novel PET Molecular Imaging for Renal Cell Carcinoma
Not applicable · China · 1 site
Registry update: 24 Dec 2025
NCT07141225
Recruiting
Application of the "Off-Clamp And Sutureless" Technique in Robot-Assisted Partial Nephrectomy
Not applicable · China · 1 site
Registry update: 5 Sept 2025
NCT06302569
Recruiting
Pembrolizumab Plus Enfortumab Vedotin in Collecting Duct and Renal Medullary Carcinoma
Phase 2 · Italy · 1 site
Registry update: 9 Sept 2025
NCT06682793
Recruiting
A Study to Evaluate the Safety and Efficacy of A2B395, an Allogeneic Logic-gated CAR T, in Participants With Solid Tumors That Express EGFR and Have Lost HLA-A*02 Expression
Phase 1/2 · United States · 10 sites
Registry update: 9 Sept 2025
NCT06934057
Recruiting
Cabozantinib and Nivolumab Among Older Patients With Renal Cell Carcinoma
Phase 4 · France · 7 sites
Registry update: 24 Sept 2025
NCT06956144
Recruiting
Exploring the Clinical Application Value of CAIX-Targeted PET Imaging in Renal Cancer Patients
Not applicable · China · 1 site
Registry update: 29 May 2025
NCT06949215
Recruiting
68Ga-NYM096 PET/ CT for the Detection of ccRCC in Presurgical Patients With Complex Cystic Renal Leision
Phase 2 · China · 1 site
Registry update: 26 May 2026
NCT07020169
Recruiting
Using 3D Kidney Model Based on Artificial Intelligence to Assist Partial Nephrectomy: A Prospective Validation Study
Not applicable · China · 1 site
Registry update: 13 Jun 2025
NCT06868186
Recruiting
A Multicenter Study of RUS NE
Not applicable · South Korea · 4 sites
Registry update: 11 Sept 2025
NCT06965192
Recruiting
Designing Visual Tools to Enhance Cancer Surgeon Decision-making
Not applicable · United States · 2 sites
Registry update: 5 Dec 2025
NCT07172802
Recruiting
A Study of GI-108, an Anti-CD73-IgG4 Fc-IL-2v Bispecific Fusion Protein, as Monotherapy in Patients With Advanced or Metastatic Solid Tumors
Phase 1/2 · South Korea · 3 sites
Registry update: 17 Sept 2026
NCT07782164
Recruiting
Irreversible Electroporation (IRE) for Treating Recurrent Pelvic Tumors (PELFIRE Study)
Not applicable · Netherlands · 1 site
Registry update: 28 Aug 2026
NCT07327489
Recruiting
Predicting Response to Immunotherapy From Analysis of Live Tumor Biopsies (ELEPHAS-05)
Not applicable · United States · 8 sites
Registry update: 29 Jun 2026
NCT06916624
Recruiting
Multicenter Study of 18F-Labeled NY104 for PET/CT Imaging in Renal Cell Carcinoma
Not applicable · China · 1 site
Registry update: 17 Sept 2026
NCT06601296
Recruiting
Radiotherapy in Combination With Checkpoint Inhibition for Patients With Metastatic Kidney Cancer
Phase 2 · United States · 1 site
Registry update: 29 Oct 2026

Ordered by registry start date. Freshness and sponsorship never change the order.